We are live on ! Find out more
BENFW icon

Beneficient Warrant

30 hedge funds and large institutions have $405K invested in Beneficient Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

3.86% more ownership

Funds ownership: 0%3.86% (+3.9%)

9% less funds holding

Funds holding: 3330 (-3)

25% less capital invested

Capital invested by funds: $537K → $405K (-$132K)

88% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 8

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.48%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
8
Closed
3
Calls
$562K
Puts
Net Calls
+$562K
Net Calls Change
-$89K

BENFW Hedge Fund Activity: Q3 2023 in Review

30 of the 6,312 institutional investors tracked by Wall St. Rank reported a position in Beneficient Warrant (BENFW) for Q3 2023, worth a combined $405K — down 25% from $537K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of BENFW and 0 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 1 added.

The largest buyer was Walleye Capital, adding an estimated $894. The largest seller was Ionic Capital Management, cutting an estimated $17.2K.

  • 30 institutional investors held Beneficient Warrant (BENFW) as of Q3 2023, down from 33 in Q2 2023.
  • Funds reported $405K of Beneficient Warrant stock for Q3 2023, down 25% quarter-over-quarter.
  • 0 funds opened new Beneficient Warrant positions in Q3 2023 and 3 closed out, a net change of -3 holders.
  • The largest Beneficient Warrant buyer in Q3 2023 was Walleye Capital, an estimated $894 added.
  • The largest Beneficient Warrant seller in Q3 2023 was Ionic Capital Management, an estimated $17.2K sold.

Based on aggregated 13F filings for Q3 2023.